Company Information & Drug Savings for Iovance Biotherapeutics, Inc. Medications

Iovance Biotherapeutics is a biotechnology company developing tumor-infiltrating lymphocyte (TIL) cell therapies for cancer. Based in San Carlos, California, Iovance created Amtagvi (lifileucel), a personalized T-cell therapy for advanced melanoma. The company’s adoptive cell therapy platform harnesses patients’ own immune cells to fight solid tumor cancers.

Iovance Biotherapeutics, Inc.

How to Contact Iovance Biotherapeutics, Inc.

Browse Medications Manufactured by Iovance Biotherapeutics, Inc.

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
NowPatient - Report Side Effects to Yellow Card or MedWatch